混合水凝的演变:用于药物输送和组织工程的下一代生物材料
Md Mohosin Rana1,2, Hector De la Hoz Siegler3
1Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC V6T 1Z7, Canada.
Gels (Basel, Switzerland)
|April 26, 2024
概括
混合水凝提供增强强度和控制释放用于生物医学用途. 这些先进材料解决了传统水凝的局限性,改善了药物输送和组织再生.
科学领域:
- 生物材料科学 生物材料科学
- 聚合物化学 聚合物化学
- 生物医学工程 生物医学工程
背景情况:
- 水凝是含水量高的水友性聚合物网络,模仿生物医学应用的细胞外矩阵.
- 传统的合成水凝由于网络缺陷而面临机械性能,扩散和生物活性方面的局限性.
- 混合水凝整合了各种各样的组件来克服这些局限性,增强强度和治疗疗效.
研究的目的:
- 审查用于生物医学应用的混合水凝系统的最新进展.
- 讨论各种类型,修改策略,以及混合水凝中的纳米/微结构集成.
- 探索创新的制造技术和生物活性分子释放机制.
主要方法:
- 对混合液凝系统的最新文献的审查.
- 分析修改策略和纳米/微观结构的整合.
- 讨论制造技术,如点击反应,3D打印和光图.
主要成果:
- 混合水凝表现出改善的机械性能,可控的药物释放和增强的生物活性.
- 创新的制造技术可以精确控制水凝结构和功能.
- 纳米/微观结构的整合进一步完善了它们在特定应用中的性能.
结论:
- 混合水凝为先进的药物输送和组织再生提供了一个有希望的平台.
- 应对当前的挑战将为这些多功能材料打开更广泛的生物医学应用.
- 对混合液凝系统的持续研究对于未来的治疗创新至关重要.
相关概念视频
Dialysis
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Downstream Processing
Downstream processing begins once fermentation is complete and involves a series of steps to recover and purify products such as acids, vitamins, antibiotics, or proteins.Cell HarvestingFor example, for intracellular protein-based products, the first step is harvesting the cells. This is typically achieved using centrifugation or filtration to separate the cells from the liquid phase.Cell Disruption for Intracellular ProductsIf the target product is intracellular, the harvested cells must be...


